208 related articles for article (PubMed ID: 12408698)
1. Scarred atrophic thyroid after I-131 therapy for Graves' disease documented at autopsy.
Shih WJ; Mitchell B; Schott JC
J Natl Med Assoc; 2002 Oct; 94(10):915-9. PubMed ID: 12408698
[TBL] [Abstract][Full Text] [Related]
2. Radioactive iodine ablation therapy: a viable option in the management of Graves' disease in Nigeria.
Adedapo KS; Fadiji IO; Orunmuyi AT; Onimode Y; Osifo BO
Afr J Med Med Sci; 2012 Dec; 41 Suppl():193-6. PubMed ID: 23678656
[TBL] [Abstract][Full Text] [Related]
3. Transient Hypothyroidism after Radioiodine for Graves' Disease: Challenges in Interpreting Thyroid Function Tests.
Sheehan MT; Doi SA
Clin Med Res; 2016 Mar; 14(1):40-5. PubMed ID: 26864507
[TBL] [Abstract][Full Text] [Related]
4. Effects of radioiodine therapy in hyperthyroidism (thyroid function, thyroid volume, Graves' ophtalmopathy, thyrotoxic heart disease).
Ursu HI; Dumitriu L; Grigorie D; Simescu M; Vaida E; Belgun M; Popovici D
Rom J Endocrinol; 1993; 31(3-4):155-63. PubMed ID: 7697064
[TBL] [Abstract][Full Text] [Related]
5. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
Franklyn JA; Daykin J; Holder R; Sheppard MC
QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
[TBL] [Abstract][Full Text] [Related]
6. High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease.
Alexander EK; Larsen PR
J Clin Endocrinol Metab; 2002 Mar; 87(3):1073-7. PubMed ID: 11889166
[TBL] [Abstract][Full Text] [Related]
7. A predictive mathematical model for the calculation of the final mass of Graves' disease thyroids treated with 131I.
Traino AC; Di Martino F; Grosso M; Monzani F; Dardano A; Caraccio N; Mariani G; Lazzeri M
Phys Med Biol; 2005 May; 50(9):2181-91. PubMed ID: 15843745
[TBL] [Abstract][Full Text] [Related]
8. Pregnancy after definitive treatment for Graves' disease--does treatment choice influence outcome?
Elston MS; Tu'akoi K; Meyer-Rochow GY; Tamatea JA; Conaglen JV
Aust N Z J Obstet Gynaecol; 2014 Aug; 54(4):317-21. PubMed ID: 24576228
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
[TBL] [Abstract][Full Text] [Related]
10. Transient hypothyroidism after iodine-131 treatment of Graves' disease.
Gómez JM; Virgili N; Soler J; Fernández M; Montaña E
Thyroidology; 1989 Dec; 1(3):149-52. PubMed ID: 2484879
[TBL] [Abstract][Full Text] [Related]
11. Influence of compensated radioiodine therapy on thyroid volume and incidence of hypothyroidism in Graves' disease.
Nygaard B; Hegedüs L; Gervil M; Hjalgrim H; Hansen BM; Søe-Jensen P; Hansen JM
J Intern Med; 1995 Dec; 238(6):491-7. PubMed ID: 9422034
[TBL] [Abstract][Full Text] [Related]
12. Radioactive iodine therapy in Graves' hyperthyroidism.
Sankar R; Sripathy G
Natl Med J India; 2000; 13(5):246-51. PubMed ID: 11190053
[TBL] [Abstract][Full Text] [Related]
13. Relapse of Graves' disease 23 years after treatment with radioactive iodine (131I).
Hegele RA; Volpé R
J Clin Lab Immunol; 1985 Oct; 18(2):103-5. PubMed ID: 3841162
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
Bakker SC; Zanin DE; Zweers EJ
Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
[TBL] [Abstract][Full Text] [Related]
15. Long-term effect of radioiodine therapy on the thyroid antibodies in the patients of Graves' disease with postirradiation hypothyroidism.
Chang TC; Chang CC; Chen FW; Liaw KY
Taiwan Yi Xue Hui Za Zhi; 1986 Dec; 85(12):1177-82. PubMed ID: 2880926
[No Abstract] [Full Text] [Related]
16. Changes in graves' ophthalmopathy after radioiodine and anti-thyroid drug treatment of Graves' disease from 2 prospective, randomized, open-label, blinded end point studies.
Chen DY; Schneider PF; Zhang XS; Luo XY; He ZM; Chen TH
Exp Clin Endocrinol Diabetes; 2014 Jan; 122(1):1-6. PubMed ID: 24203649
[TBL] [Abstract][Full Text] [Related]
17. Predictive factors of failure in a fixed 15 mCi 131I-iodide therapy for Graves' disease.
Moura-Neto A; Mosci C; Santos AO; Amorim BJ; de Lima MC; Etchebehere EC; Tambascia MA; Ramos CD; Zantut-Wittmann DE
Clin Nucl Med; 2012 Jun; 37(6):550-4. PubMed ID: 22614185
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment with betamethasone of patients with Graves' disease given radioiodine therapy: thyroid autoantibody responses and outcome of therapy.
Gamstedt A; Karlsson A
J Clin Endocrinol Metab; 1991 Jul; 73(1):125-31. PubMed ID: 2045463
[TBL] [Abstract][Full Text] [Related]
19. [Radioiodine versus surgery in the treatment of Graves' hyperthyroidism].
Jukić T; Stanicić J; Petric V; Kusić Z
Lijec Vjesn; 2010; 132(11-12):355-60. PubMed ID: 21294325
[TBL] [Abstract][Full Text] [Related]
20. Radioiodine therapy in Graves' hyperthyroidism: determination of individual optimum target dose.
Haase A; Bähre M; Lauer I; Meller B; Richter E
Exp Clin Endocrinol Diabetes; 2000; 108(2):133-7. PubMed ID: 10826521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
